These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19668515)

  • 21. Protein kinase C inhibitors in the treatment of diabetic retinopathy. Review.
    Gálvez MI
    Curr Pharm Biotechnol; 2011 Mar; 12(3):386-91. PubMed ID: 20939796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV
    Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the prevention and management of diabetic retinopathy and diabetic eye disease in India: A synopsis.
    Gilbert C; Gordon I; Mukherjee CR; Govindhari V
    Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S63-S66. PubMed ID: 31937733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy.
    Berrocal MH; Acaba LA; Chenworth ML
    Curr Diab Rep; 2019 Sep; 19(10):106. PubMed ID: 31529405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the treatment of diabetic retinopathy.
    Yam JC; Kwok AK
    Hong Kong Med J; 2007 Feb; 13(1):46-60. PubMed ID: 17277392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Algorithms for Diagnosis of Diabetic Retinopathy and Diabetic Macula Edema- A Review.
    Suriyasekeran K; Santhanamahalingam S; Duraisamy M
    Adv Exp Med Biol; 2021; 1307():357-373. PubMed ID: 32166636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing diabetic macular edema: The leading cause of diabetes blindness.
    Romero-Aroca P
    World J Diabetes; 2011 Jun; 2(6):98-104. PubMed ID: 21860693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential Impact of Unilateral and Bilateral Classifications of Diabetic Retinopathy and Diabetic Macular Edema on Vision-Related Quality of Life.
    Man RE; Fenwick EK; Sabanayagam C; Li LJ; Tey CS; Soon HJ; Cheung GC; Tan GS; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4655-60. PubMed ID: 27603726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective.
    Bunch KL; Abdelrahman AA; Caldwell RB; Caldwell RW
    Front Physiol; 2022; 13():831616. PubMed ID: 35250632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrates and statins in the treatment of diabetic retinopathy.
    Ansquer JC; Crimet D; Foucher C
    Curr Pharm Biotechnol; 2011 Mar; 12(3):396-405. PubMed ID: 20939802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial progenitor cells in diabetic retinopathy.
    Lois N; McCarter RV; O'Neill C; Medina RJ; Stitt AW
    Front Endocrinol (Lausanne); 2014; 5():44. PubMed ID: 24782825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetic retinopathy. Current opinion on pathophysiology, diagnostics and therapy].
    Sacha E
    Przegl Lek; 2005; 62(4):238-42. PubMed ID: 16229243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rubosixtaurin and other PKC inhibitors in diabetic retinopathy and macular edema. Review.
    Gálvez MI
    Curr Diabetes Rev; 2009 Feb; 5(1):14-7. PubMed ID: 19199893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for and managing diabetic retinopathy: current approaches.
    Bloomgarden ZT
    Am J Health Syst Pharm; 2007 Sep; 64(17 Suppl 12):S8-14. PubMed ID: 17720893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
    Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
    Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between the classification of diabetic macular edema and its related factors].
    Liu LY; Dong FT; Li H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):797-802. PubMed ID: 18595262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging pharmacotherapies for diabetic macular edema.
    Furlani BA; Meyer CH; Rodrigues EB; Maia M; Farah ME; Penha FM; Holz FG
    Expert Opin Emerg Drugs; 2007 Nov; 12(4):591-603. PubMed ID: 17979601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan.
    Kitano S; Sakamoto T; Goto R; Fukushima A; Vataire AL; Hikichi Y
    J Med Econ; 2019 Mar; 22(3):254-265. PubMed ID: 30550375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 21st Century treatment of diabetic retinopathy.
    Chibber R; Chibber S; Kohner EM
    Expert Rev Endocrinol Metab; 2007 Sep; 2(5):623-631. PubMed ID: 30736125
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.